ROYAL PHARMACEUTICALS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 22 Feb 2025)
What this means for you
Registered since 23 Jan 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87112891
- Registration number
- 5387582
- Mark type
- Stylized text
- Filed
- 22 Jul 2016
- Published for opposition
- 11 Jul 2017
- Registered
- 23 Jan 2018
- Attorney of record
- Gregory F. Kotchick
Goods and services
- Class 035 — Advertising and business services: Distributorships and wholesale distributorships and retail store services featuring branded FDA approved and unapproved pharmaceutical products and vitamins for sale to national distributors, wholesalers, retail chains and health systems
Owner
- Royal Pharmaceuticals, LLC, Wall, NJ, US
- Royal Pharmaceuticals, LLC, Manasquan, NJ, US
- Royal Pharmaceuticals, LLC, Manasquan, NJ, US
Prosecution history
- 22 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 07 Aug 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 03 Aug 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Jan 2024 — TEAS SECTION 8 & 15 RECEIVED
- 23 Jan 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jan 2018 — REGISTERED-PRINCIPAL REGISTER
- 19 Dec 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Dec 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Dec 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Nov 2017 — USE AMENDMENT FILED
- 13 Dec 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Nov 2017 — TEAS STATEMENT OF USE RECEIVED
- 05 Sept 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT